Form D — Xact Bio, Inc.
0002157427-26-000001 · filed Sep 28, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $17,999,997
- Total sold
- $9,999,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Xact Bio, Inc.
- CIK
- 2157427
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 501 BOYLSTON STREET, 9TH FLOOR
BOSTON, MA 02116 - Phone
- 000-000-0000
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Eric Green · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Uciane Scarlett · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Chengjung Lai · DirectorBoston, MA Find on LinkedIn ↗
-
Jian Shao · DirectorBoston, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗